11:38 AM EST - Tekmira Pharmaceuticals Corp. : reported a narrower second-quarter net loss of $2.3 million or $$0.04 per share compared with $4.8 million or $0.14 per share in the prior-year period. Revenue from research and development collaborations, licensing fees and milestone payments for the quarter was $3.8 million, higher than $2.5 million in the comparable period. Tekmira Pharmaceuticals Corp.
shares T.TKM are trading up $0.02 at $1.07.
